Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Hoffmann-La Roche
Instituto do Cancer do Estado de São Paulo
Rigshospitalet, Denmark
Hoffmann-La Roche
University of California, San Francisco